23 - Thrombophilia Flashcards
composition of venous thrombi vs arterial thrombi
venous - RBCs
arterial - platelets
virchow’s triad
endothelial injury
abnl blood flow
hypercoagulability
activated protein C affect on PTT
prolong - degrades factor Va and VIIIa
APC resistance gene mutation
factor V Leiden mutation - makes V less susceptible to cleavage by APC
clinical consequences / management of Factor V Leiden
relatively common, risk for venous (not arterial) thrombosis
overall significance not known, prophylactic anticoag NOT recommended
prothrombin gene mutation
inc synth of prothrombin > 3 fold inc thrombotic risk
common in caucasians
protein C
vit K dependent anticoagulant
made in liver
what activates protein C
thrombin/thrombomodulin complex
how does APC reduce coagulation?
inactivates factor Va and VIIIa w/ protein S as cofactor
also a powerful inhibitor of PAI-1 (plasminogen activator inhibitor)
congenital protein C deficiency inheritance pattern
AD inheritance, variable penetrance
clinical presentation/effects of heterozygous and homozygous protein C deficiency
heterozygotes - 5-10 fold inc in venous thrombosis risk, rarely symptomatic until >20yo. assoc w/ pregnancy loss
homozygotes - infants w/ DIC or purpura fulminans
protein S
vit K dependent
60% binds to C4b-BP, no anticoag fn
40% free - cofactor for APC, anticoag
causes of acquired protein C and S deficiency
liver dz DIC acute thromboses post surg BC pill, hormone replacement warfarin / vit K deficiency
L-asparginase - C only
ARDS - C only
nephrotic syndrome - S only
antithrombin
binds w/ heparin-like molecs > conf change
complex inactivates thrombin and F.Xa
accelerates dissoc of F.VIIa-TF complex
causes of antithrombin defi
congenital - AD
acquired - similar to prot C/S